Nitika C. Panakkal, Rajagopal Kadavigere, Suresh Sukumar, Ravishankar N
{"title":"Influence of Body Mass Index and Abdominal Circumference on Radiation Dose During Abdominopelvic Computed Tomography","authors":"Nitika C. Panakkal, Rajagopal Kadavigere, Suresh Sukumar, Ravishankar N","doi":"10.13005/bpj/2741","DOIUrl":null,"url":null,"abstract":"Background: Contrast-enhanced examinations of the abdomen region have a greater radiation exposure due to the multiphase abdominal computed tomography (CT) protocols. The use of automatic tube current modulation is known to reduce radiation dose and maintain or improve image quality for abdominal CT. However, using automatic tube current modulation can increase radiation dose for individuals with a larger body habitus. Objectives: The study aimed to assess the influence of body mass index and abdominal circumference on the effective dose for routinely performed contrast-enhanced abdomen and pelvis scans. Methods: A total of 160 subjects referred for routine CT abdomen and pelvis were included in the study and categorised into three groups according to their body mass index (BMI) [underweight: <18.5 kg/m2, normal: 18.5-24.9 kg/m2, overweight: 25-29.9 kg/m2 and obese: (≥30 kg/m2]. All the scans were performed on a 128 MDCT scanner by Philips. The effective dose was calculated from the dose length product using region-specific conversion factors. Results: The effective dose was found to be 21.47 ± 2 mSv for the underweight group, 22.75± 2.3 mSv for the normal group, 25.02 ± 2.8 for the overweight group, and 29.7 ± 6.7 mSv for the obese group. Conclusion: The study reported a 32.39 % increase in effective dose for obese patients. The study also reported a significant increase in effective dose as BMI and abdominal circumference increased.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"35 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical and Pharmacology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13005/bpj/2741","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Contrast-enhanced examinations of the abdomen region have a greater radiation exposure due to the multiphase abdominal computed tomography (CT) protocols. The use of automatic tube current modulation is known to reduce radiation dose and maintain or improve image quality for abdominal CT. However, using automatic tube current modulation can increase radiation dose for individuals with a larger body habitus. Objectives: The study aimed to assess the influence of body mass index and abdominal circumference on the effective dose for routinely performed contrast-enhanced abdomen and pelvis scans. Methods: A total of 160 subjects referred for routine CT abdomen and pelvis were included in the study and categorised into three groups according to their body mass index (BMI) [underweight: <18.5 kg/m2, normal: 18.5-24.9 kg/m2, overweight: 25-29.9 kg/m2 and obese: (≥30 kg/m2]. All the scans were performed on a 128 MDCT scanner by Philips. The effective dose was calculated from the dose length product using region-specific conversion factors. Results: The effective dose was found to be 21.47 ± 2 mSv for the underweight group, 22.75± 2.3 mSv for the normal group, 25.02 ± 2.8 for the overweight group, and 29.7 ± 6.7 mSv for the obese group. Conclusion: The study reported a 32.39 % increase in effective dose for obese patients. The study also reported a significant increase in effective dose as BMI and abdominal circumference increased.
期刊介绍:
Biomedical and Pharmacology Journal (BPJ) is an International Peer Reviewed Research Journal in English language whose frequency is quarterly. The journal seeks to promote research, exchange of scientific information, consideration of regulatory mechanisms that affect drug development and utilization, and medical education. BPJ take much care in making your article published without much delay with your kind cooperation and support. Research papers, review articles, short communications, news are welcomed provided they demonstrate new findings of relevance to the field as a whole. All articles will be peer-reviewed and will find a place in Biomedical and Pharmacology Journal based on the merit and innovativeness of the research work. BPJ hopes that Researchers, Research scholars, Academician, Industrialists etc. would make use of this journal for the development of science and technology. Topics of interest include, but are not limited to: Biochemistry Genetics Microbiology and virology Molecular, cellular and cancer biology Neurosciences Pharmacology Drug Discovery Cardiovascular Pharmacology Neuropharmacology Molecular & Cellular Mechanisms Immunology & Inflammation Pharmacy.